Zheng YF[Author] - Search Results

Year	Number of Results
1982	1
1984	5
1987	1
1989	1
1992	1
1993	2
1994	1
1995	1
1997	1
1998	5
1999	2
2001	2
2002	9
2003	3
2004	7
2005	7
2006	7
2007	9
2008	16
2009	19
2010	26
2011	47
2012	36
2013	57
2014	42
2015	31
2016	41
2017	29
2018	34
2019	28
2020	29
2021	7

1

Physical properties of 5 root canal sealers.

Zhou HM, Shen Y, Zheng W, Li L, Zheng YF, Haapasalo M. Zhou HM, et al. Among authors: zheng yf. J Endod. 2013 Oct;39(10):1281-6. doi: 10.1016/j.joen.2013.06.012. Epub 2013 Aug 27. J Endod. 2013. PMID: 24041392

2

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial.

Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, Shiono YN, Saito H, Kuriyama S, Tohno E, Endo T, Fukao A, Tsuji I, Yamaguchi T, Ohashi Y, Fukuda M, Ishida T; J-START investigator groups. Ohuchi N, et al. Among authors: zheng yf. Lancet. 2016 Jan 23;387(10016):341-348. doi: 10.1016/S0140-6736(15)00774-6. Epub 2015 Nov 5. Lancet. 2016. PMID: 26547101 Clinical Trial.

3

Current challenges and concepts of the thermomechanical treatment of nickel-titanium instruments.

Shen Y, Zhou HM, Zheng YF, Peng B, Haapasalo M. Shen Y, et al. Among authors: zheng yf. J Endod. 2013 Feb;39(2):163-72. doi: 10.1016/j.joen.2012.11.005. J Endod. 2013. PMID: 23321225 Review.

4

Increased Homer1-mGluR5 mediates chronic stress-induced depressive-like behaviors and glutamatergic dysregulation via activation of PERK-eIF2α.

Li MX, Li Q, Sun XJ, Luo C, Li Y, Wang YN, Chen J, Gong CZ, Li YJ, Shi LP, Zheng YF, Li RC, Huang XL, Xiong QJ, Chen H. Li MX, et al. Among authors: zheng yf. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109682. doi: 10.1016/j.pnpbp.2019.109682. Epub 2019 Jun 29. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 31265863

5

A novel tri-culture model for neuroinflammation.

Zheng YF, Zhou X, Chang D, Bhuyan DJ, Zhang JP, Yu WZ, Jiang XS, Seto SW, Yeon SY, Li J, Li CG. Zheng YF, et al. J Neurochem. 2021 Jan;156(2):249-261. doi: 10.1111/jnc.15171. Epub 2020 Sep 27. J Neurochem. 2021. PMID: 32891068

6

LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.

Zhang J, Hu K, Yang YQ, Wang Y, Zheng YF, Jin Y, Li P, Cheng L. Zhang J, et al. Among authors: zheng yf. Cell Death Dis. 2020 Sep 11;11(9):741. doi: 10.1038/s41419-020-02967-z. Cell Death Dis. 2020. PMID: 32917856 Free PMC article.

7

Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales.

Fan L, Li Y, Chen JY, Zheng YF, Xu XM. Fan L, et al. Among authors: zheng yf. Cancer Lett. 2019 Aug 1;456:23-28. doi: 10.1016/j.canlet.2019.03.050. Epub 2019 Apr 5. Cancer Lett. 2019. PMID: 30959079 Review.

8

Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions.

Yan YF, Zheng YF, Ming PP, Deng XX, Ge W, Wu YG. Yan YF, et al. Among authors: zheng yf. Brief Funct Genomics. 2019 Mar 22;18(2):147-156. doi: 10.1093/bfgp/ely029. Brief Funct Genomics. 2019. PMID: 30247518 Review.

9

Electrochemical Sensor for Determination of Pb²⁺ Based on Gold Nanoparticles.

Yin HY, Zheng YF, Wang L. Yin HY, et al. Among authors: zheng yf. J Nanosci Nanotechnol. 2020 Jun 1;20(6):3356-3360. doi: 10.1166/jnn.2020.17415. J Nanosci Nanotechnol. 2020. PMID: 31748027

10

Inhibition of calcineurin/NFATc4 signaling attenuates ventilator‑induced lung injury.

Li M, Fang XZ, Liu XT, Zheng YF, Xie YB, Ma XD, Xia Y, Shao DH. Li M, et al. Among authors: zheng yf. Mol Med Rep. 2020 Feb;21(2):607-614. doi: 10.3892/mmr.2019.10851. Epub 2019 Nov 26. Mol Med Rep. 2020. PMID: 31789412 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results